We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Low-Temperature Sterilization System Maximizes Efficiency

By HospiMedica International staff writers
Posted on 24 Feb 2017
A new low-temperature hydrogen peroxide (H2O2) sterilization system uses proprietary algorithms to minimize workflow interruptions and cycle cancellations.

The Advanced Sterilization Products STERRAD 100NX System with ALLClear Technology includes features that simplify system operation and automatically monitor sterility conditions, providing pre-sterilization cycle load conditioning, load checks, and system checks to reduce operator error, while improving productivity in central sterile services departments (CSSDs), assisting them to maximize efficiency and comply with government and facility requirements. More...
Features include a large rectangular chamber, touch-screen display control, and an H2O2monitor.

The system features several cycle options, including a 47-minute standard cycle for most surgical instruments; a 42-minute flex cycle for single-channel flexible endoscopes; a 24-minute express cycle for fast turnaround of da Vinci 3-D endoscopes, rigid telescopes, rechargeable batteries, and other instruments; and a 60-minute DUO cycle for processing flexible endoscopes and cameras together. The system is available as a pass-through sterilizer for CSSDs that need to separate clean and sterile areas, and can also be paired with the ASP ACCESS system to automate data sharing across all connected ASP systems and hospital networks.

“We developed the new STERRAD 100NX System with ALLClear technology to help CSSDs deliver instruments to operating rooms faster and more consistently, providing doctors and patients with the devices they need, when they need them,” said Suneel Shorey, vice president of ASP Global Marketing. “This new system is the first in a series of innovations we plan to introduce globally in 2017 to help elevate the standard of care in sterilization and build on our heritage as a leader in infection prevention.”

H2O2 is a strong oxidant used as a chemical sterilizing agent for heat or temperature sensitive articles. The biggest advantage of H2O2 as a sterilant is the short cycle time, but there are also drawbacks, such as material compatibility issues. For example, paper products cannot be sterilized because of a process called cellulostics, in which the H2O2 would be completely absorbed by the paper product. There are also limitations on the length and diameter of lumens that can be effectively sterilized.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.